357 related articles for article (PubMed ID: 30576233)
1. Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease.
Qian Q; Zhang J; He FP; Bao WX; Zheng TT; Zhou DM; Pan HY; Zhang H; Zhang XQ; He X; Sun BG; Luo BY; Chen C; Peng GP
FASEB J; 2019 Mar; 33(3):4404-4417. PubMed ID: 30576233
[TBL] [Abstract][Full Text] [Related]
2. Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.
Zhang J; Hu M; Teng Z; Tang YP; Chen C
J Neurosci; 2014 Nov; 34(45):14919-33. PubMed ID: 25378159
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects.
Long JM; Ray B; Lahiri DK
J Biol Chem; 2014 Feb; 289(8):5184-98. PubMed ID: 24352696
[TBL] [Abstract][Full Text] [Related]
4. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
6. miR-15b reduces amyloid-β accumulation in SH-SY5Y cell line through targetting NF-κB signaling and BACE1.
Li J; Wang H
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29961672
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo.
Yang G; Song Y; Zhou X; Deng Y; Liu T; Weng G; Yu D; Pan S
Mol Med Rep; 2015 Aug; 12(2):3081-8. PubMed ID: 25955795
[TBL] [Abstract][Full Text] [Related]
8. BAG-1M co-activates BACE1 transcription through NF-κB and accelerates Aβ production and memory deficit in Alzheimer's disease mouse model.
Shi Z; Hong Y; Zhang K; Wang J; Zheng L; Zhang Z; Hu Z; Han X; Han Y; Chen T; Yao Q; Cui H; Hong W
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2398-2407. PubMed ID: 28502705
[TBL] [Abstract][Full Text] [Related]
9. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.
Kimura R; Devi L; Ohno M
J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133
[TBL] [Abstract][Full Text] [Related]
10. Circulating Small Extracellular Vesicle-Derived miR-342-5p Ameliorates Beta-Amyloid Formation via Targeting Beta-site APP Cleaving Enzyme 1 in Alzheimer's Disease.
Dong Z; Gu H; Guo Q; Liu X; Li F; Liu H; Sun L; Ma H; Zhao K
Cells; 2022 Nov; 11(23):. PubMed ID: 36497090
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1.
Zhu HC; Wang LM; Wang M; Song B; Tan S; Teng JF; Duan DX
Brain Res Bull; 2012 Sep; 88(6):596-601. PubMed ID: 22721728
[TBL] [Abstract][Full Text] [Related]
12. MiR-216a-5p ameliorates learning-memory deficits and neuroinflammatory response of Alzheimer's disease mice via regulation of HMGB1/NF-κB signaling.
Shao P
Brain Res; 2021 Sep; 1766():147511. PubMed ID: 33957091
[TBL] [Abstract][Full Text] [Related]
13. miR-186 is decreased in aged brain and suppresses BACE1 expression.
Kim J; Yoon H; Chung DE; Brown JL; Belmonte KC; Kim J
J Neurochem; 2016 May; 137(3):436-45. PubMed ID: 26710318
[TBL] [Abstract][Full Text] [Related]
14. miR-98-5p Acts as a Target for Alzheimer's Disease by Regulating Aβ Production Through Modulating SNX6 Expression.
Li Q; Li X; Wang L; Zhang Y; Chen L
J Mol Neurosci; 2016 Dec; 60(4):413-420. PubMed ID: 27541017
[TBL] [Abstract][Full Text] [Related]
15. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
Devi L; Ohno M
Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
[TBL] [Abstract][Full Text] [Related]
16. Replenishment of microRNA-188-5p restores the synaptic and cognitive deficits in 5XFAD Mouse Model of Alzheimer's Disease.
Lee K; Kim H; An K; Kwon OB; Park S; Cha JH; Kim MH; Lee Y; Kim JH; Cho K; Kim HS
Sci Rep; 2016 Oct; 6():34433. PubMed ID: 27708404
[TBL] [Abstract][Full Text] [Related]
17. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
Zhang J; Wang R
Exp Gerontol; 2021 Feb; 144():111180. PubMed ID: 33279663
[TBL] [Abstract][Full Text] [Related]
18. The microRNA-455 Null Mouse Has Memory Deficit and Increased Anxiety, Targeting Key Genes Involved in Alzheimer's Disease.
Swingler TE; Niu L; Pontifex MG; Vauzour D; Clark IM
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008980
[TBL] [Abstract][Full Text] [Related]
19. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.
Devi L; Ohno M
Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-132-3p alleviates neuron apoptosis and impairments of learning and memory abilities in Alzheimer's disease by downregulation of HNRNPU stabilized BACE1.
Qu J; Xiong X; Hujie G; Ren J; Yan L; Ma L
Cell Cycle; 2021 Nov; 20(21):2309-2320. PubMed ID: 34585626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
